Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 106
Filter
1.
Toxicol Rep ; 7: 752-758, 2020.
Article in English | MEDLINE | ID: mdl-32612935

ABSTRACT

Tobacco-specific nitrosamines (TSNAs) have been of concern to the public health community for decades and their reduction through agricultural practices, plant breeding, and tobacco processing has also been a decades-long industry effort. Despite those efforts, TSNAs, though lower, continue to be constituents of concern in tobacco products. This paper examines the TSNA levels of dark air-cured, dark fire-cured, and burley tobaccos purchased in the United States by U.S. Smokeless Tobacco Company LLC (USSTC) and of nine finished USSTC moist smokeless tobacco products. TSNA values of the incoming purchased tobaccos and the finished products showed considerable variability. For the incoming tobaccos, the coefficient of variation was generally more than 100 % for each tobacco type and for each of the measured TSNAs. The relative TSNA variability of the finished tobacco products was also considerable, averaging approximately 25 %. It was also found that the measured values for the finished products averaged well above the proposed FDA NNN proposed product standard of 1.0 µg/g dry weight. Because of the large variability in NNN values, products would have to average well below FDA's proposed product standard to be consistently compliant.

3.
Environ Monit Assess ; 148(1-4): 149-58, 2009 Jan.
Article in English | MEDLINE | ID: mdl-18193487

ABSTRACT

The UK is legally required by the EU Water Framework Directive (WFD) to improve the environmental quality of inland and coastal waters in the coming years. Historic metal mine sites are recognised as an important source of some of the elements on the WFD priority chemicals list. Despite their contamination potential, such sites are valued for their heritage and for other cultural and scientific reasons. Remediating historic mining areas to control the contamination of stream waters, whilst also preserving the integrity of the mine site, is a challenge but might be achieved by novel forms of remediation. In this study, we have carried out environmental monitoring at a historic, and culturally-sensitive, lead-silver mine site in southwest England and have undertaken a pilot experiment to investigate the potential for a novel, non-invasive remediation method at the site. Concentrations of Pb and Zn in mine spoil were clearly elevated with geometric mean concentrations of 6,888 and 710 microg g(-1), respectively. Mean concentrations of Pb in stream waters were between 21 and 54 microg l(-1), in exceedance of the WFD environmental quality standard (EQS) of 7.2 microg l(-1) (annual average). Mean Zn concentrations in water were between 30 and 97 microg l(-1), compared to the UK EQS of 66.5 microg l(-1) (average). Stream sediments within, and downstream from, the mining site were similarly elevated, indicating transport of mine waste particles into and within the stream. We undertook a simple trial to investigate the potential of hydroxyapatite, in the form of bonemeal, to passively remove the Pb and Zn, from the stream waters. After percolating through bonemeal in a leaching column, 96-99% of the dissolved Pb and Zn in stream water samples was removed.


Subject(s)
Environmental Pollutants/chemistry , Environmental Restoration and Remediation/methods , Industrial Waste , Metals/chemistry , Mining , Durapatite/chemistry , England , Environmental Monitoring , Geologic Sediments/chemistry , Humans , Rivers/chemistry
4.
J Immunol ; 167(3): 1431-9, 2001 Aug 01.
Article in English | MEDLINE | ID: mdl-11466362

ABSTRACT

The I domain of the integrin LFA-1 possesses a ligand binding interface that includes the metal ion-dependent adhesion site. Binding of the LFA-1 ligand, ICAM-1 to the metal ion-dependent adhesion site is regulated by the I domain allosteric site (IDAS). We demonstrate here that intracellular signaling leading to activation of LFA-1 binding to ICAM-1 is regulated at the IDAS. Inhibitory mutations in or proximal to the IDAS are dominant to cytoplasmic signals that activate binding to ICAM-1. In addition, mutational activation at the IDAS greatly increases the binding of lymphocyte-expressed LFA-1 to ICAM-1 in response to PMA, but does not result in constitutive binding. Binding of a novel CD18 activation epitope mAb to LFA-1 in response to soluble ICAM-1 binding was also blocked by inhibitory and was enhanced by activating IDAS mutations. Surface plasmon resonance using soluble wild-type LFA-1 and an IDAS mutant of LFA-1 indicate that the IDAS can regulate a 6-fold change in the K(d) of ICAM-1 binding. The K(d) of wild-type LFA-1 (1.2 x 10(-1) s(-1)) differed with that of the activating IDAS mutant (1.9 x 10(-2) s(-1)), but their K(a) values were identical (2.2 x 10(5) M(-1)s(-1)). We propose that IDAS regulates the binding of LFA-1 to ICAM-1 activated by intracellular signals. IDAS can control the affinity state of LFA-1 with concomitant I domain and CD18 conformational changes.


Subject(s)
Lymphocyte Function-Associated Antigen-1/metabolism , Allosteric Site/genetics , Amino Acid Sequence , Animals , CHO Cells , COS Cells , Cell Adhesion/genetics , Clone Cells , Cricetinae , Humans , Intercellular Adhesion Molecule-1/metabolism , Kinetics , Ligands , Lymphocyte Function-Associated Antigen-1/physiology , Lymphocytes/metabolism , Molecular Sequence Data , Mutagenesis, Site-Directed , Protein Binding/genetics , Protein Structure, Tertiary/genetics , Signal Transduction/genetics , Surface Plasmon Resonance
5.
N Z Med J ; 114(1125): 50, 2001 Feb 09.
Article in English | MEDLINE | ID: mdl-11277486
6.
N Z Med J ; 113(1108): 152, 2000 Apr 28.
Article in English | MEDLINE | ID: mdl-10872439
7.
Proc Natl Acad Sci U S A ; 97(10): 5231-6, 2000 May 09.
Article in English | MEDLINE | ID: mdl-10805782

ABSTRACT

The leukocyte integrin, lymphocyte function-associated antigen 1 (LFA-1) (CD11a/CD18), mediates cell adhesion and signaling in inflammatory and immune responses. To support these functions, LFA-1 must convert from a resting to an activated state that avidly binds its ligands such as intercellular adhesion molecule 1 (ICAM-1). Biochemical and x-ray studies of the Mac-1 (CD11b/CD18) I domain suggest that integrin activation could involve a conformational change of the C-terminal alpha-helix. We report the use of NMR spectroscopy to identify CD11a I domain residues whose resonances are affected by binding to ICAM-1. We observed two distinct sites in the CD11a I domain that were affected. As expected from previous mutagenesis studies, a cluster of residues localized around the metal ion-dependent adhesion site (MIDAS) was severely perturbed on ICAM-1 binding. A second cluster of residues distal to the MIDAS that included the C-terminal alpha-helix of the CD11a I domain was also affected. Substitution of residues in the core of this second I domain site resulted in constitutively active LFA-1 binding to ICAM-1. Binding data indicates that none of the 20 substitution mutants we tested at this second site form an essential ICAM-1 binding interface. We also demonstrate that residues in the I domain linker sequences can regulate LFA-1 binding. These results indicate that LFA-1 binding to ICAM-1 is regulated by an I domain allosteric site (IDAS) and that this site is structurally linked to the MIDAS.


Subject(s)
CD18 Antigens/chemistry , Intercellular Adhesion Molecule-1/chemistry , Lymphocyte Function-Associated Antigen-1/chemistry , Allosteric Site , Amino Acid Substitution , Animals , Binding Sites , COS Cells , Cell Adhesion , Crystallography, X-Ray , Humans , Ligands , Lymphocyte Function-Associated Antigen-1/genetics , Lymphocyte Function-Associated Antigen-1/physiology , Macrophage-1 Antigen/chemistry , Models, Molecular , Mutagenesis, Site-Directed , Nuclear Magnetic Resonance, Biomolecular/methods , Protein Structure, Secondary , Recombinant Proteins/chemistry , Transfection
11.
Cell ; 95(2): 269-77, 1998 Oct 16.
Article in English | MEDLINE | ID: mdl-9790533

ABSTRACT

Guanine nucleotide exchange factors for the Rho family of GTPases contain a Dbl homology (DH) domain responsible for catalysis and a pleckstrin homology (PH) domain whose function is unknown. Here we describe the solution structure of the N-terminal DH domain of Trio that catalyzes nucleotide exchange for Rac1. The all-alpha-helical protein has a very different structure compared to other exchange factors. Based on site-directed mutagenesis, functionally important residues of the DH domain were identified. They are all highly conserved and reside in close proximity on two a helices. In addition, we have discovered a unique capability of the PH domain to enhance nucleotide exchange in DH domain-containing proteins.


Subject(s)
Guanine Nucleotide Exchange Factors , Nucleotides/metabolism , Phosphoproteins/chemistry , Phosphoproteins/genetics , Protein Serine-Threonine Kinases/chemistry , Protein Serine-Threonine Kinases/genetics , Proto-Oncogene Proteins/genetics , Blood Proteins/chemistry , Blood Proteins/genetics , Magnetic Resonance Spectroscopy , Molecular Sequence Data , Mutagenesis , Phosphoproteins/metabolism , Protein Serine-Threonine Kinases/metabolism , Protein Structure, Secondary , Protein Structure, Tertiary , Sequence Homology, Amino Acid
12.
Proc Natl Acad Sci U S A ; 95(14): 7909-14, 1998 Jul 07.
Article in English | MEDLINE | ID: mdl-9653114

ABSTRACT

Cytohesin-1 (B2-1) is a guanine nucleotide exchange factor for human ADP ribosylation factor (Arf) GTPases, which are important for vesicular protein trafficking and coatamer assembly in the cell. Cytohesin-1 also has been reported to promote cellular adhesion via binding to the beta2 integrin cytoplasmic domain. The solution structure of the Sec7 domain of cytohesin-1, which is responsible for both the protein's guanine nucleotide exchange factor function and beta2 integrin binding, was determined by NMR spectroscopy. The structure consists of 10 alpha-helices that form a unique tertiary fold. The binding between the Sec7 domain and a soluble, truncated version of human Arf-1 was investigated by examining 1H-15N and 1H-13C chemical shift changes between the native protein and the Sec7/Arf-1 complex. We show that the binding to Arf-1 occurs through a large surface on the C-terminal subdomain that is composed of both hydrophobic and polar residues. Structure-based mutational analysis of the cytohesin-1 Sec7 domain has been used to identify residues important for binding to Arf and for mediating nucleotide exchange. Investigations into the interaction between the Sec7 domain and the beta2 integrin cytoplasmic domain suggest that the two proteins do not interact in the solution phase.


Subject(s)
Cell Adhesion Molecules/chemistry , GTP-Binding Proteins/metabolism , ADP-Ribosylation Factors , Amino Acid Sequence , Binding Sites , Biological Transport , CD18 Antigens/metabolism , Cell Adhesion Molecules/metabolism , Cloning, Molecular , Guanine Nucleotide Exchange Factors , Humans , Molecular Sequence Data , Protein Binding , Protein Folding , Protein Structure, Secondary
13.
Cell Signal ; 9(7): 519-29, 1997 Nov.
Article in English | MEDLINE | ID: mdl-9419816

ABSTRACT

A cDNA encoding a calmodulin-stimulated 3',5'-cyclic nucleotide phosphodiesterase (PDE) was isolated from a human brain cDNA library. The cDNA, designated HSPDE1B1, encoded a protein of 536 amino acids that shared 96% sequence identity with the bovine "63 kDa" calmodulin-stimulated PDE. The recombinant protein had cyclic nucleotide phosphodiesterase activity that was stimulated approximately 2-fold by Ca2+/calmodulin and preferred cGMP as substrate. In addition, the enzymatic activity of HSPDE1B1 was inhibited by phosphodiesterase inhibitors with potencies similar to that displayed toward the bovine PDE1 enzymes: IBMX approximately equal to 8-methoxymethyl-IBMX > vinpocetine approximately equal to zaprinast > cilostamide > rolipram. HSPDE1B1 mRNA was found predominantly in the brain. Lower mRNA levels were found in heart and skeletal muscle. In situ hybridisation of brain revealed expression of HSPDE1B1 predominately in neuronal cells of the cerebellum, hippocampus and caudate. The HSPDE1B1 gene was mapped to human chromosome 12. A partial genomic sequence of HSPDE1B1 was isolated and shown to contain two splice junctions that are conserved in the rat PDE4 and the Drosophila dunce genes.


Subject(s)
3',5'-Cyclic-AMP Phosphodiesterases/genetics , 3',5'-Cyclic-GMP Phosphodiesterases/genetics , Calmodulin/pharmacology , Chromosomes, Human, Pair 12 , Phosphoric Diester Hydrolases , 3',5'-Cyclic-AMP Phosphodiesterases/metabolism , 3',5'-Cyclic-GMP Phosphodiesterases/metabolism , Amino Acid Sequence , Animals , Base Sequence , Blotting, Northern , Brain/metabolism , Cattle , Cell Line , Chromosome Mapping , Cloning, Molecular , Conserved Sequence , Cyclic Nucleotide Phosphodiesterases, Type 1 , DNA, Complementary , Humans , Isoenzymes/genetics , Isoenzymes/metabolism , Mice , Molecular Sequence Data , RNA, Messenger , Rats , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Saccharomyces cerevisiae/metabolism , Sequence Homology, Amino Acid , Tissue Distribution
15.
Med J Aust ; 165(1): 18-21, 1996 Jul 01.
Article in English | MEDLINE | ID: mdl-8676773

ABSTRACT

OBJECTIVES: To examine the reliability of relative work value assessment in general practice consultations and to determine whether different methods of assessing work produce consistent rankings. DESIGN: Cross-sectional observational assessment of general practice consulations. SETTING: General practices in Victoria between October 1991 and October 1992. PARTICIPANTS: 686 patients attending one of 58 general practitioners (GPs) drawn from a random, stratified sample. METHODS: Each participating GP had one day of consultations videotaped. They rated the work value of each consultation by using a magnitude estimation scale relative to a reference vignette. Three GP observers independently applied the same scale to the videotaped consultations. After three months, the observers applied a second measurement of work value, a compensation scale (also relative to the reference vignette), to the videotaped consultations. Duration of consultation was the third rating method. MAIN OUTCOME MEASURES: The reliability of work value assessment for each scale. Consultation rank order correlation coefficients among all rating methods. RESULTS: Observer reliability was high for both scales. Practising GPs showed lower levels of reliability in assessing the work value of their consultations. Strong positive correlations were found for consultation rankings among the observer scales and duration of the consultation. The duration of the consultation emerged as an important predictor of consultation work value. CONCLUSIONS: Scaling methods appear to be of little value to the practising GP in reliably assessing the relative work value of their consultations; training in the use of these scales may improve their reliability. However, the duration of consultation may be a reasonable proxy for relative work value assessment in general practice consultations.


Subject(s)
Family Practice/economics , Fee-for-Service Plans/economics , Relative Value Scales , Australia , Humans , Observer Variation , Reproducibility of Results
17.
J Biol Chem ; 271(2): 796-806, 1996 Jan 12.
Article in English | MEDLINE | ID: mdl-8557689

ABSTRACT

cDNAs corresponding to two human calcium, calmodulin (CaM)-regulated 3',5'-cyclic nucleotide phosphodiesterases (PDEs) were isolated. One, Hcam1 (PDE1A3), corresponds to the bovine 61-kDa CaM PDE (PDE1A2). The second, Hcam3 (PDE1C), represents a novel phosphodiesterase gene. Hcam1 encodes a 535-amino acid protein that differs most notably from the bovine 61-kDa CaM PDE by the presence of a 14-amino acid insertion and a divergent carboxyl terminus. RNase protection studies indicated that Hcam1 is represented in human RNA from several tissues, including brain, kidney, testes, and heart. Two carboxyl-terminal splice variants for Hcam3 were isolated. One, Hcam3b (PDE1C1), encodes a protein 634 amino acids (72 kDa) in length. The other, Hcam3a (PDE1C3), diverges from Hcam3b 4 amino acids from the carboxyl terminus of Hcam3b, and extends an additional 79 amino acids. All the cDNAs isolated for Hcam3a are incomplete; they do not include the 5'-end of the open reading frame. Northern analysis revealed that both splice variants were expressed in several tissues, including brain and heart, and that there may be additional splice variants. Amino-truncated recombinant proteins were expressed in yeast and characterized biochemically. Hcam3a has a high affinity for both cAMP and cGMP and thus has distinctly different kinetic parameters from Hcam1, which has a higher affinity for cGMP than for cAMP. Both PDE1C enzymes were inhibited by isobutylmethylxanthine, 8-methoxymethyl isobutylmethylxanthine, zaprinast, and vinpocetine.


Subject(s)
3',5'-Cyclic-AMP Phosphodiesterases/isolation & purification , DNA, Complementary/isolation & purification , 3',5'-Cyclic-AMP Phosphodiesterases/genetics , Amino Acid Sequence , Animals , Base Sequence , Cattle , Cloning, Molecular , DNA, Complementary/genetics , Humans , Molecular Sequence Data , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification , Sequence Alignment , Sequence Analysis
18.
N Z Med J ; 108(995): 90, 1995 Mar 08.
Article in English | MEDLINE | ID: mdl-7677831
19.
N Z Med J ; 107(988): 440, 1994 Oct 26.
Article in English | MEDLINE | ID: mdl-7970349
SELECTION OF CITATIONS
SEARCH DETAIL
...